Obesity management Market is expected to grow at the average CAGR of +8.4% during 2019-2025. Obesity management Market is expected to reach US$ 6.2 billion by 2025 from US$ 4.17 billion in 2015. However, several side effects of drugs, regulatory issues and high cost are the major restraints for the market.
Obesity has a clear and profound impact on the health of our society and the economy, and is a very relevant and topical area as the prevalence increases. As a physical therapist, treatment of obesity according to a biomedical model of health will lead to a reductionist approach focused on the treatment of physical problems of excess body fat by addressing energy balance. But as the understanding and development of obesity grows, it must be practiced. When designing a patient-specific treatment plan, the psychosocial dimensions of this complex disorder should be taken into account, so in these efforts a bio psychosocial model of health can help.
Request Sample Copy of this Report@: https://healthcareintelligencemarkets.com/request_sample.php?id=29360
This market research report on analyzes the growth prospects for the key vendors operating in this market space including Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)
Obesity Management Market has been segmented on the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others. On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.
Key areas discussed in report include the Americas, Asia Pacific (APAC), and Europe. North America dominates the global obesity management market. High medical costs and easily accessible medical support systems are one of the key factors supporting North American market growth. Many Americans are affected by obesity and related disorders. Europe ranked second in the rankings. A well-established health care system and a high level of awareness are driving the market in Europe. Market growth in the Asia Pacific region is also expected to be impressive during the forecast period. This region shows considerable market potential. The focus on improving health care, government-initiated awareness campaigns and improving medical penetration rates represents a favorable environment for market players operating in the region.
Get Reasonable Discount on this Premium Report @: https://healthcareintelligencemarkets.com/ask_for_discount.php?id=29360
Highlights of the Global Obesity Management Market:
- What will the market size and the growth rate be in 2026?
- What are the key factors driving the Global Obesity Management Market?
- What are the key market trends impacting the growth of the market?
- What are the challenges to market growth?
- Who are the key vendors in the Global Obesity Management Market?
- What are the market opportunities and threats faced by the vendors in this market?
- Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA.
This report provides an effective business outlook, different case studies from various top-level industry experts, business owners, and policymakers have been included to get a clear vision about business methodologies to the readers. SWOT and Porter’s Five model have been used for analyzing the Obesity Management Market on the basis of strengths, challenges and global opportunities in front of the businesses.
For More Information: https://healthcareintelligencemarkets.com/enquiry_before_buying.php?id=29360
At HealthCare Intelligence Markets
Address: 90, State Office Center,
90, State Street Suite 700,
Albany, NY 12207
Phone: +1 (888) 616-2766